Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia
Shoulson, I.
Advances in Neurology 37: 259-266
1983
ISSN/ISBN: 0091-3952 PMID: 6134445 Document Number: 213075
Document emailed within 1 workday
Related Documents
Grimes, J.D. 1982: Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients Canadian Medical Association Journal 126(5): 468Lohr, J.B.; Lohr, M.A.; Wasli, E.; Hilliard, B.; Larson, L.; Vardiman, E.; Wade, L.; Jeste, D.V. 1987: Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates Psychopharmacology Bulletin 23(1): 211-214
Seeman, P.; Staiman, A.; Lee, T.; Chau-Wong, M. 1974: The membrane actions of tranquilizers in relation to neuroleptic-induced parkinsonism and tardive dyskinesia Advances in Biochemical Psychopharmacology 9(0): 137-148
Lieberman, A.N.; Gopinathan, G.; Neophytides, A.; Pasternack, P. 1986: Use of carbidopa as an adjuvant to levodopa/carbidopa therapy in patients with Parkinson's disease New York State Journal of Medicine 86(12): 655-656
Spivak, B.; Mester, R.; Abesgaus, J.; Wittenberg, N.; Adlersberg, S.; Gonen, N.; Weizman, A. 1997: Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients Journal of Clinical Psychiatry 58(7): 318-322
De Fraites, E.G.; Davis, K.L.; Berger, P.A. 1977: Coexisting tardive dyskinesia and parkinsonism: a case report Biological Psychiatry 12(2): 267-272
Timberlake, W.H. 1970: Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders Neurology 20(12): 31-35
Kulkarni, S.K.; Naidu, P.S. 2003: Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives Drugs of Today 39(1): 19-49
Huh, L.; Lee, B.Ju. 2015: Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report Psychiatria Danubina 27(2): 195-197
Nagao, T.; Ohshimo, T.; Mitsunobu, K.; Sato, M.; Otsuki, S. 1979: Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor Biological Psychiatry 14(3): 509-523
Calabresi, P.; Giacomini, P.; Centonze, D.; Bernardi, G. 2000: Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Annals of Neurology 47(4 Suppl 1): S60
Clayton, A.H. 1995: Antidepressant-induced tardive dyskinesia: review and case report Psychopharmacology Bulletin 31(2): 259-264
Häggström, J.E. 1981: Tardive dyskinesia caused by metoclopramide therapy Lakartidningen 78(5): 361
Rubovits, R. 1977: Altered receptor sensitivity following chronic drug administration in man: the tardive dyskinesia model Psychopharmacology Bulletin 13(1): 49-50
Keenan, R.E. 1970: The Eaton collaborative study of levodopa therapy in parkinsonism: a summary Neurology 20(12): Suppl: 46-65
Lee, S.T.; Lu, C.S. 1996: Ventrolateral thalamotomy for dyskinesia following levodopa therapy of Parkinson's disease Journal of the Formosan Medical Association 95(12): 943-945
Bourgeois, M. 1977: Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital L'Encephale 3(4): 299-320
Gaillard-Sizaret, C.; Gaillard, P. 1979: Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials Therapie 34(5): 555-574
Hauser, R.A. 2004: Levodopa/carbidopa/entacapone (Stalevo) Neurology 62(1 Suppl 1): S64-S71
Klivényi, P.ét.; Vécsei, L.ás.ó 2014: Clinical studies with levodopa/carbidopa intestinal gel Ideggyogyaszati Szemle 67(1-2): 5-8